KDM1A and neuroblastoma: Our results demonstrate that KDM1A inhibition in neuroblastoma models induces differentiation independently of retinoic acid, and adding KDM1A inhibition to combination therapies independent of retinoic acid or even as a substitute for retinoic acid (to maintain a differentiation-inducing effect) may boost treatment success.